Detalhe da pesquisa
1.
Activity of trastuzumab emtansine (T-DM1) in 3D cell culture.
Breast Cancer Res Treat
; 188(1): 65-75, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34091830
2.
Fluorescent multiplexing of 3D spheroids: Analysis of biomarkers using automated immunohistochemistry staining platform and multispectral imaging.
J Cell Biochem
; 121(12): 4974-4990, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692912
3.
High-Resolution Epitope Mapping and Affinity Binding Analysis Comparing a New Anti-Human LAG3 Rabbit Antibody Clone to the Commonly Used Mouse 17B4 Clone.
Antibodies (Basel)
; 11(4)2022 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36278613
4.
Impact of Pre-Analytical Conditions on the Antigenicity of Lung Markers: ALK and MET.
Appl Immunohistochem Mol Morphol
; 28(5): 331-338, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-30724750
5.
A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
J Thorac Oncol
; 12(5): 804-813, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28147239
6.
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
J Thorac Oncol
; 12(2): 208-222, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913228
7.
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay.
J Thorac Oncol
; 8(8): 1019-31, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23817194